Olga Boix

496 total citations
4 papers, 16 citations indexed

About

Olga Boix is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Olga Boix has authored 4 papers receiving a total of 16 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Oncology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Olga Boix's work include HER2/EGFR in Cancer Research (2 papers), Advanced Breast Cancer Therapies (2 papers) and Cancer therapeutics and mechanisms (1 paper). Olga Boix is often cited by papers focused on HER2/EGFR in Cancer Research (2 papers), Advanced Breast Cancer Therapies (2 papers) and Cancer therapeutics and mechanisms (1 paper). Olga Boix collaborates with scholars based in Spain and Palestinian Territory. Olga Boix's co-authors include Sonia Emperador, Elena García‐Arumí, M.‐Eugenia Armengod, Julio Montoya, Magda Villarroya, Salvador Meseguer, Víctor Moreno, Alejandro Navarro, Maria J. de Miguel and Begoña Bermejo and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and Breast Cancer Research.

In The Last Decade

Olga Boix

3 papers receiving 16 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Olga Boix Spain	3	11	4	3	3	2	4	16
Esha Banerjee United States	2	10 0.9×	3 0.8×	5 1.7×	4 1.3×	2 1.0×	3	21
Yanjuan Ma China	3	13 1.2×	3 0.8×	3 1.0×	3 1.0×	2 1.0×	3	18
Nancy Roche United States	2	9 0.8×	4 1.0×	5 1.7×	3 1.0×	2 1.0×	5	21
Danielle Pasternack Canada	2	13 1.2×	4 1.0×	3 1.0×	3 1.0×		2	20
Sara Penchev United States	3	8 0.7×	5 1.3×	2 0.7×	4 1.3×		6	13
Changquan Ling China	3	12 1.1×	3 0.8×	4 1.3×	4 1.3×		3	17
Dor Simkin Israel	2	6 0.5×	7 1.8×	2 0.7×	3 1.0×	2 1.0×	3	12
Éva Somogyiné Ezer Hungary	3	7 0.6×	3 0.8×	5 1.7×	3 1.0×		5	14
Stefano Minardi Italy	2	7 0.6×	5 1.3×	3 1.0×	3 1.0×		4	9
Patrick J. O’Hearn United States	2	13 1.2×	5 1.3×	2 0.7×	6 2.0×		2	18

Countries citing papers authored by Olga Boix

Since Specialization

Citations

This map shows the geographic impact of Olga Boix's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olga Boix with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olga Boix more than expected).

Fields of papers citing papers by Olga Boix

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olga Boix. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olga Boix. The network helps show where Olga Boix may publish in the future.

Co-authorship network of co-authors of Olga Boix

This figure shows the co-authorship network connecting the top 25 collaborators of Olga Boix. A scholar is included among the top collaborators of Olga Boix based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olga Boix. Olga Boix is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

4 of 4 papers shown

1.

Calles, Antonio, Alejandro Navarro, Maria J. de Miguel, et al.. (2025). Lurbinectedin Plus Pembrolizumab in Relapsed SCLC: The Phase I/II LUPER Study. Journal of Thoracic Oncology. 20(7). 969–982. 4 indexed citations

2.

Gión, María, Nuria Ribelles, José Luis Alonso-Romero, et al.. (2025). Ipatasertib combined with non-taxane chemotherapy for patients with previously treated advanced triple-negative breast cancer: the PATHFINDER phase IIa trial. Breast Cancer Research. 27(1). 141–141.

3.

García, José Manuel Pérez, María Gión, Nuria Ribelles, et al.. (2024). Ipatasertib (IPA) combined with non-taxane chemotherapy (CT) for patients (pts) with previously treated advanced triple-negative breast cancer (aTNBC): The PATHFINDER phase IIa trial.. Journal of Clinical Oncology. 42(16_suppl). 1098–1098. 3 indexed citations

4.

Meseguer, Salvador, Olga Boix, Magda Villarroya, et al.. (2017). microRNA-mediated differential expression of TRMU, GTPBP3 and MTO1 in cell models of mitochondrial-DNA diseases. Scientific Reports. 7(1). 6209–6209. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact